Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C MutationFerdinandos Skoulidis, Ramaswamy Govindan, Bob T. Li et al.|New England Journal of Medicine|2021Cited by 1.8k
Osimertinib after Chemoradiotherapy in Stage III <i>EGFR</i> -Mutated NSCLCShun Lu, Suresh S. Ramalingam, Terufumi Kato et al.|New England Journal of Medicine|2024Cited by 291
Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: WJOG9717L StudyHirotsugu Kenmotsu, Toshiaki Takahashi, Takehito Shukuya et al.|Journal of Thoracic Oncology|2022Cited by 158
Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorterMasaru Watanabe, Toshiaki Takahashi|Cancer Science|2018Cited by 42
Artificial Intelligence–Powered Prediction of <i>ALK</i> Gene Rearrangement in Patients With Non–Small-Cell Lung CancerYukihiro Terada, Toshiaki Takahashi|JCO Clinical Cancer Informatics|2022Cited by 9